Author name: akshay dhamal

Air Cooled Condenser Market Size to Attain USD 8.17 Billion by 2034

Energy and Power

The global Air Cooled Condenser (ACC) market size is projected to grow from USD 5.07 billion in 2025 to approximately USD 8.17 billion by 2034, expanding at a steady compound annual growth rate (CAGR) of 5.44% during this period. This growth is propelled by mounting environmental concerns, stringent energy efficiency regulations, technological advancements, and surging […]

Alzheimer Therapeutics Market Size to Attain USD 33.62 Billion by 2034

Healthcare

The global Alzheimer therapeutics market size is projected to experience robust growth, with expected market valuation hitting USD 33.62 billion by 2034 from USD 6.49 billion in 2025, growing at a CAGR of 20.06% between 2025 and 2034. This surge is primarily fueled by an increasing elderly population worldwide and revolutionary advances in disease-modifying therapies

Architectural Window Film Market Size to Reach USD 7.74 Billion by 2034, Growing at a Steady CAGR of 4.10%

Chemical and Material

Market Expansion Driven by Energy Efficiency, Technological Innovation, and Sustainability Trends The global architectural window film market is poised for solid growth, with valuations expected to rise from USD 5.39 billion in 2025 to approximately USD 7.74 billion by 2034. This represents a compound annual growth rate (CAGR) of 4.10% over the forecast period from

Personalized Testing and Supplements Market Size to Attain USD 7.74 Billion by 2034

Healthcare, Press Release

Rapid Rise in Demand for Data-Driven Nutrition Spurs Industry Forecasts: North America Leads, Asia Pacific Surges The global Personalized Testing and Supplements Market is set to soar from $5.39 billion in 2025 to approximately $7.74 billion by 2034, growing at a relentless CAGR of 16.22%. The market’s acceleration reflects surging demand for wellness analytics and

Case Study: Biogen’s Leqembi Redefines Alzheimer’s Treatment Landscape: A Breakthrough in Disease Modification and Global Access

Case Studies

Headquarters: Cambridge, Massachusetts, U.S.Offering: Leqembi (Lecanemab) – Amyloid Beta-directed Antibody Case Study Biogen Inc., a leading biotechnology company specializing in neurodegenerative and rare diseases, achieved a breakthrough in Alzheimer’s therapeutics through the global expansion of Leqembi (Lecanemab), its amyloid beta-directed antibody developed in collaboration with Eisai Co., Ltd. Following full approval by the U.S. Food

India’s Solar Manufacturing Boom: From Growth to Overcapacity

News

India’s solar module manufacturing capacity is set to exceed 125 GW by 2025, over three times the domestic demand of roughly 40 GW leading to a potential inventory surplus of 29 GW, according to Wood Mackenzie. This rapid surge has been powered by the government’s Production Linked Incentive (PLI) scheme, which has accelerated factory expansion

Molecular Cytogenetics Market Size to Reach USD 7.82 Billion by 2034, Expanding at an 11.81% CAGR

Healthcare, Press Release

The global molecular cytogenetics market is poised for robust growth, driven by rising genetic disorder prevalence and advancements in genomic technologies for precise chromosomal analysis. Unlocking Genetic Insights: Molecular Cytogenetics Market on the Rise with High Growth Potential The molecular cytogenetics market size is valued at USD 2.86 billion in 2025, is projected to grow

Case Study: GE Healthcare’s Discovery NM/CT 870 System in Nuclear Medicine

Case Studies

Company Name: GE HealthcareHeadquarters: Chicago, Illinois, U.S.Offering: Nuclear Medicine Software for Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) Case Study GE Healthcare, a global leader in healthcare technology, unveiled its latest innovation in nuclear medicine the Discovery NM/CT 870 system. This state-of-the-art hybrid system combines advanced Positron Emission Tomography (PET) with

Battleground India: OpenAI, Google, and Perplexity Spark an AI Freebie War

News

India has emerged as the newest battleground for artificial intelligence giants — OpenAI, Google, and Perplexity — as they compete to capture the attention of millions of users. Their playbook? Offer free AI access today to build long-term loyalty tomorrow. The strategy draws heavily from Reliance Jio’s disruptive model — give users a free taste,

Scroll to Top